Pittsburgh Oculoplastic Assoc Pittsburgh, PA - 15213

Pittsburgh Oculoplastic Assoc is categorized under Doctors in Pittsburgh, PA and active since 1979.

Pittsburgh Oculoplastic Assoc was established in 1979, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact George F Buerger Jr at the company’s single location by writing to 3471 5th Avenue # 1115, Pittsburgh, Pennsylvania PA 15213 or by phoning (412) 681-4220. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Pittsburgh Oculoplastic Assoc
Contact Person: George F Buerger Jr
Address: 3471 5th Avenue # 1115, Pittsburgh, Pennsylvania 15213
Phone Number: (412) 681-4220
Website Address: eyelidsurgeon.com
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 1979
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Pittsburgh Oculoplastic Assoc was started in 1979 to provide professional Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact George F Buerger Jr for inquiries that concern Pittsburgh Oculoplastic Assoc by calling the company number (412) 681-4220, as your correspondence is most welcome. Additionally, the physical location of the single location of Pittsburgh Oculoplastic Assoc can be found at the coordinates 40.44029,-79.96059 as well as the street address 3471 5th Avenue # 1115 in Pittsburgh, Pennsylvania 15213.

For its online presence, you may visit Pittsburgh Oculoplastic Assoc’s website at eyelidsurgeon.com and engage with its social media outlets through on Twitter and on Facebook.